Sentences with phrase «pet is a patient»

Despite years of experience, it never gets easier to handle the illness of a pet, whether that pet is a patient or a member of my own family.

The pet is a patient at a veterinary clinic, and is receiving treatment for IBD or is suspected to have IBD.

When your pet is a patient here, you are part of our family.

If your pet is a patient at Florida Veterinary Referral Center, you may enter your Patient ID number below to view patient radiographs or ultrasound images.

pastcurrentfuture If past or current, which of your pets are patients here?

Fortunately, you can put all your worries to rest when your pet is a patient at Lakeview Pet Hospital.

Not exact matches

Other studies, meanwhile, are examining tryp's potential efficacy as an antifungal agent; and as a prognostic indicator in patients with brain cancer (as seen by increased uptake of the amino acid on a PET scan).

I went looking for a patient guide, and was advised to call Prof. David Duff, of the University of British Columbia's Peter A. Allard School of Law, who is the primary author of the 2015 page - turner The Taxation of Business Organizations in Canada.What, haven't read it?

For one, it's made it clear that using tools like PET scans and cerebrospinal fluid testing can help pinpoint which patients have amyloid present in the brain for the treatments to act on.

(2nd Peter 3:9)... Instead he is patient with you, not wanting anyone to perish, but everyone to come to repentance.

«2 Peter 3:9 The Lord is not slow to fulfill his promise as some count slowness, but is patient toward you, not wishing that any should perish, but that all should reach repentance.»

A number of hospitals now use a variety of animals to improve the emotional well - being of their patients, despite the difficulties of having pets in such institutions.

The pets whose company helped in the well - being of these patients were dogs, cats, fish and even an iguana.

In a later study of the well - being of coronary patients, Holden (1981) reported that ownership of a pet among ninety - three patients was the strongest predictor of survival, stronger even than human relationships.

[14] St Peter of Damascus makes the point that it is always possible to make a new start by means of repentance, «As long as you do not surrender yourself willingly to the enemy, your patient endurance, combined with self - reproach, will suffice for your salvation.»

Editorial FAITH Magazine January — February 2011 «The Lord is not slow about his promise... but is patient towards you» 2 Peter 3:9 Part One: How is Evil Possible?

Nor do the authors pick up on the same pope's astonishing invitation of the leaders of other churches and their theologians to a «patient and fraternal dialogue» to help find ways in which the pastoral and doctrinal ministry of Peter might be differently exercised in the service of universal Christian unity» a move that opened the prospect of a «reformed papacy» such as Luther, at least, was willing to contemplate.

Instead He is patient with you, not wanting anyone to perish, but everyone to come to repentance» (2 Peter 3:8 - 9).

2 Peter 3:9 The Lord is not slow about His promise, as some count slowness, but is patient toward you, not wishing for any to perish but for all to come to repentance.

A surgical center affiliated with St. Peter's Hospital in Albany has been hit by the second - largest computer breach of patient records in New York state since 2016.

A surgical center affiliated with St. Peter's Hospital has been hit by the second - largest computer breach of patient records in New York state since 2016.

-- the choice to prioritise pet projects, such as free schools, elected police commissioners, and David Cameron's disastrous top down NHS reorganisation - even as school repairs are cancelled, police officers lose their jobs, and patients wait longer.

«Clinicians in dengue - endemic areas should be aware of this association, especially for patients with dengue who have neurologic deficits or for patients with stroke who have unexplained fever,» writes Dr. Chia - Hung Kao, Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan, with coauthors.

«The research is novel because it looks at the impact of PSMA PET / CT on patient responses to treatment, not just on whether the PET scan results in changed management,» explains Louise Emmett, MD, of the St. Vincent's Hospital, Sydney, Australia.

Also, since MR involves no radiation and the scan allows a longer PET acquisition time, the patient's exposure is lower than with CT..

«We're bereft of any [Food and Drug Administration]-- approved therapy for any primary mitochondrial disease, [and we're] always searching,» says Peter Stacpoole of the University of Florida in Gainesville, who has long cared for patients with these conditions.

Such infections «are the really nasty things for patients,» says immunologist Peter Nibbering at Leiden University Medical Center in the Netherlands.

In «Evaluation of 18F - Fluoride PET / MR and PET / CT in Patients with Foot Pain of Unclear Cause,» researchers compared the quality and diagnostic performance of 18F - fluoride PET / MR to those of 18F - fluoride PET / CT in 22 patients for whom the specific diagnosis was inconclusive after clinical examination and radiPatients with Foot Pain of Unclear Cause,» researchers compared the quality and diagnostic performance of 18F - fluoride PET / MR to those of 18F - fluoride PET / CT in 22 patients for whom the specific diagnosis was inconclusive after clinical examination and radipatients for whom the specific diagnosis was inconclusive after clinical examination and radiography.

Nevertheless, neurologist Peter Rothwell, a researcher at Oxford University and specialist on stroke, has found that 80 percent of such procedures were performed on low - risk patients without symptoms — an inappropriate group.

«Blocking both of these proteins could be a treatment that is beneficial for the majority of lung cancer patients,» said Dr. Habib, Associate Professor of Neurology and Neurotherapeutics with UT Southwestern's Peter O'Donnell Jr..

To explore this question, Peter Jones, PhD, and his team — then at the University of Massachusetts and now at University of Nevada, Reno — investigated in arhinia patients patterns of methylation — which can suppress transcription of a DNA segment — at a region of the genome known to be altered in FSHD2, revealing that the arhinia patients often had identical methylation changes in the same region.

These results demonstrate that noninvasive imaging of EGFR activating mutation status in primary and metastatic tumors with 18F - MPG PET / CT is a valid strategy for stratifying NSCLC patients for EGFR - TKI treatment.

The first - in - human PET / CT imaging of 75 patients with 18F - MPG was performed to show that this tracer can be used as a companion diagnostic to identify NSCLC patients with EGFR activating mutant tumors (primary tumor or metastatic) with 84.3 % accuracy.

«With 18F - MPG PET / CT imaging, we were able to quantitate EGFR - activating mutation status in NSCLC patients (primary tumor or metastatic) and directly determine / visualize the location (s) and morphology of the NSCLCs.»

Detecting the presence of tumor estrogen or HER2 receptors with PET scans would enable oncologists to examine all sites of cancer for each patient, choose the appropriate drug treatment more quickly, monitor the tumor for changes that would necessitate a switch to another treatment, and even evaluate how well a drug is hitting its receptor targets.

After the PET scans were complete, the researchers calculated how much glucose was being consumed by the most active hemisphere of the patients» brains relative to the healthy controls.

In the new study, researchers used FDG - PET scans to analyze the resting cerebral metabolic rate — the amount of energy being used by the tissue — of 131 patients with a so - called disorder of consciousness and 28 healthy controls.

In one recent trial, researchers showed that a combination of FDG and HER2 - targeted PET imaging was 100 percent accurate in predicting patient responses to a costly new anti-HER2 breast cancer drug.

«Although the trial by McManus et al does not settle all questions regarding self - titration based on self - measurement, it is an important step toward adaptation of treatment for patients who want to actively take part in their own risk - factor control,» write Peter M. Nilsson, M.D., Ph.D., of Skane University Hospital, Malmo, Sweden, and Fredrik H. Nystrom, M.D., Ph.D., of Linkoping University, Linkoping, Sweden, in an accompanying editorial.

«FDG PET shows tumor DNA levels in blood are linked to NSCLC aggressiveness: Insights derived from FDG PET could improve treatment selection for patients with advanced non-small cell lung cancer.»

This study of 37 patients (24 men and 13 women, ages 51 to 80) who have never been treated with chemotherapy found direct correlation of the amount of cfDNA with tumor metabolism (based on PET - derived parameters), but not with metabolic tumor volume.

«It's the first clinical trial of a drug with this action in patients with cancer,» says Peter Lewis, the director of research and development.

Further, trials for new drugs targeting at - risk patients can be ramped up significantly if a simple, non-invasive blood test can replace costly imaging like PET scan.

Study co-author Peter Sandercock, Professor of Neurology, University of Edinburgh said, «I can not over-emphasise how useful these analyses are — they provide the type of clear information that patients and their families need when weighing the benefits and risks of this important treatment.»

Ga - 68 PSMA PET / CT, F - 18 FMC PET / CT and diagnostic CT were undertaken in all patients sequentially between January and April 2015 and assessed by masked, experienced nuclear medicine physicians.

The tumour has completely disappeared in the two patients after three to four treatments and can no longer be detected neither by PET / CT imaging nor by the tumour marker PSA (Prostate - specific antigen), whose blood level is often elevated in men with prostate cancer.

Professor Peter Johnson, Cancer Research UK's chief clinician, said: «Although we're making great progress, we still have more to do for people with ovarian cancer, as only one in three patients survive for 10 years or longer.

«We are evaluating patient and disease factors that affect the value of FDG PET / CT for systemic staging of locally advanced breast cancer,» said study coauthor Molly Parsons.

Peter Aldhous's article discusses US restrictions on patients being given treatments based on their own stem cells (10 August, p...

Reportedly, the Spanish patient's pet dog will be euthanized as part of the effort to control spread of the infection, although evidence of Ebola transmission via dogs is not clear.